Luk Van Parijs

Last updated

Luk Van Parijs was an associate professor of biology at the Massachusetts Institute of Technology (MIT) Center for Cancer Research. After investigating for a year, MIT fired Van Parijs for research misconduct. Van Parijs admitted to fabricating and falsifying research data in a paper, several unpublished manuscripts, and grant applications. In March 2011, Van Parijs pleaded guilty in a U.S. District Court in Boston to one count of making a false statement on a federal grant application. The government asked Judge Denise Casper for a 6-month jail term because of the seriousness of the fraud, which involved a $2-million grant. After several prominent scientists including Van Parijs' former post-doc supervisor pleading for clemency on his behalf, on 13 June, Van Parijs was finally sentenced six months of home detention with electronic monitoring, plus 400 hours of community service and a payment to MIT of $61,117 - restitution for the already-spent grant money that MIT had to return to the National Institutes of Health. [1]

Contents

Van Parijs' area of research was in the use of short-interference RNA in studying disease mechanisms, especially in autoimmune diseases. He was studying normal immune cell function and defects in these cells during disease development.

Timeline

Literature corrections

(Original paper, correction; Chronological by literature correction - w/in institution of origin.)

Harvard papers

Caltech papers

MIT papers

(Each correction retracts data.)

News media

(Chronological)

  1. Robert L. Hotz, "Caltech President Who Raised School's Profile to Step Down" (Los Angeles Times, 4 Oct. 2005, P. A1)
  2. MIT News Office, "MIT professor dismissed for research misconduct" (press release) 27 Oct. 2005; published in News Office's TechTalk 2 Nov. 2005 (50(7): 3, 6)
  3. Boston Globe, "MIT professor is fired over fabricated data," 28 Oct. 2005
  4. Samuel Reich, Eugenie (2005) MIT professor sacked for fabricating data. NewScientist.com (28 Oct.)
  5. New York Times, "M.I.T. Dismisses a Researcher, Saying He Fabricated Some Data," 28 Oct. 2005
  6. The Tech (MIT student paper), "MIT Fires Professor Van Parijs for Using Fake Data in Papers," 28 Oct. 2005
  7. Boston Globe, "More doubts raised on fired MIT professor," 29 Oct. 2005
  8. Harvard Crimson, "MIT Professor Fired for Faking Data," 31 Oct. 2005
  9. The Tech, "Van Parijs’ Research at Caltech, Brigham Drawing New Scrutiny," 1 Nov. 2005
  10. TheScientist.com, "Immunologists prepare for fraud fallout," 3 Nov. 2005
  11. Dalton, R. (2005) Universities scramble to assess scope of falsified results. Nature 438(7064): 7 (3 Nov.) PMID   16267515
  12. Couzin, J. (2005) MIT terminates researcher over data fabrication. Science 310(5749): 758 (4 Nov.) PMID   16272088
  13. New Scientist, "One bad apple..." (unsigned editorial), 5 Nov. 2005
  14. Chronicle of Higher Education, "MIT Fires Biology Professor Who Admitted Faking Data," 11 Nov. 2005 (Payment or subscription required.)
  15. unsigned editorial (2006) Scientific blues. Nature Immunology 7(1): 1 (1 Jan.) PMID   16357846
  16. Reich, E.S. (2006) Bad data fail to halt patents. Nature 439(7075): 379 (26 Jan.) PMID   16437075
  17. Odling-Smee, L., Giles, J., Fuyuno, I., Cyranoski, D., & Marris, E. (2007) Misconduct Special: Where are they now? Nature 445(7125): 244-5 (18 Jan.) PMID   17230161
  18. Reich, E.S. (2007) Scientific misconduct report still under wraps. New Scientist ?(2631): 16 (24 Nov.)
  19. Reich, E.S. (2009) Former MIT biologist penalized for falsifying data. Nature.com (3 Feb.) Nature News or here
  20. Reich, E.S. (2009) Beating the science cheats. New Scientist ?(2706): 22 (2 May)

See also

Related Research Articles

Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research.

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science in 2008.

<span class="mw-page-title-main">Cytotoxic T cell</span> T cell that kills infected, damaged or cancerous cells

A cytotoxic T cell (also known as TC, cytotoxic T lymphocyte, CTL, T-killer cell, cytolytic T cell, CD8+ T-cell or killer T cell) is a T lymphocyte (a type of white blood cell) that kills cancer cells, cells that are infected by intracellular pathogens (such as viruses or bacteria), or cells that are damaged in other ways.

In academic publishing, a retraction is a mechanism by which a published paper in an academic journal is flagged for being seriously flawed to the extent that their results and conclusions can no longer be relied upon. Retracted articles are not removed from the published literature but marked as retracted. In some cases it may be necessary to remove an article from publication, such as when the article is clearly defamatory, violates personal privacy, is the subject of a court order, or might pose a serious health risk to the general public.

<span class="mw-page-title-main">Fas receptor</span> Protein found in humans

The Fas receptor, also known as Fas, FasR, apoptosis antigen 1, cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6), is a protein that in humans is encoded by the FAS gene. Fas was first identified using a monoclonal antibody generated by immunizing mice with the FS-7 cell line. Thus, the name Fas is derived from FS-7-associated surface antigen.

<span class="mw-page-title-main">CD134</span> Protein-coding gene in humans

Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor, is a member of the TNFR-superfamily of receptors which is not constitutively expressed on resting naïve T cells, unlike CD28. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; its ligand, OX40L, is also not expressed on resting antigen presenting cells, but is following their activation. Expression of OX40 is dependent on full activation of the T cell; without CD28, expression of OX40 is delayed and of fourfold lower levels.

<span class="mw-page-title-main">Cancer immunology</span> Study of the role of the immune system in cancer

Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance and immunoediting are based on protection against development of tumors in animal systems and (ii) identification of targets for immune recognition of human cancer.

<span class="mw-page-title-main">Death receptor 3</span> Protein found in humans

Death receptor 3 (DR3), also known as tumor necrosis factor receptor superfamily member 25 (TNFRSF25), is a cell surface receptor of the tumor necrosis factor receptor superfamily which mediates apoptotic signalling and differentiation. Its only known TNFSF ligand is TNF-like protein 1A (TL1A).

<span class="mw-page-title-main">Lymphocyte-activation gene 3</span>

Lymphocyte-activation gene 3, also known as LAG-3, is a protein which in humans is encoded by the LAG3 gene. LAG3, which was discovered in 1990 and was designated CD223 after the Seventh Human Leucocyte Differentiation Antigen Workshop in 2000, is a cell surface molecule with diverse biologic effects on T cell function. It is an immune checkpoint receptor and as such is the target of various drug development programs by pharmaceutical companies seeking to develop new treatments for cancer and autoimmune disorders. In soluble form it is also being developed as a cancer drug in its own right.

Carlo Maria Croce is an Italian–American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct.

<span class="mw-page-title-main">Eomesodermin</span> Protein-coding gene in the species Homo sapiens

Eomesodermin also known as T-box brain protein 2 (Tbr2) is a protein that in humans is encoded by the EOMES gene.

Silvia Bulfone-Paus is an Italian immunologist. She is the chair of the Research Center Borstel's Department of Immunology and Cell Biology and also serves as professor of Immunobiology at the University of Manchester School of Medicine.

Amy J. Wagers is the Forst Family Professor of Stem Cell and Regenerative Biology at Harvard University and Harvard Medical School, an investigator in islet cell and regenerative biology at the Joslin Diabetes Center, and principal faculty of the Harvard Stem Cell Institute. She is co-chair of the Department of Stem Cells and Regenerative Biology at Harvard Medical School.

Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin. He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

<span class="mw-page-title-main">Arturo Casadevall</span> Cuban-American scientist

Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.

Joyoti Basu is an Indian biochemist, cell biologist and a senior professor at the Bose Institute. Known for her studies on the membrane structure of red blood cells, Basu is an elected fellow of all three major Indian science academies, namely the National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy, as well as the Indian Society for Chemical Biology. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2002.

Sunil Kumar Manna is an Indian immunologist and the head of the immunology lab of the Centre for DNA Fingerprinting and Diagnostics. He is known for his studies on cell signaling and apoptosis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2009.

Jacques Banchereau is an internationally prominent French American immunologist and molecular biologist. As of 2022, he is Chief Scientific Officer at Immunai. He was formerly professor and director of immunological sciences at the Jackson Laboratory for Genomic Medicine and also the former chief science officer, senior vice president, and DTA head of inflammation & virology at Hoffman-La Roche. He is best known for his extensive research on dendritic cells with Nobel Laureate Ralph M. Steinman. He is the fifth most cited immunologist ranked by Times Higher Education's report.

References

  1. Samuel Reich, Eugenie (2011). "Biologist spared jail for grant fraud". Nature. 474 (7353): 552. doi: 10.1038/474552a . PMID   21720338.